| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |